CLINICAL_TRIALS
trial_result
· 2015-03-03
Clinical Trial Update: A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area [Phase 4]
Summary
A Phase 4 trial reports a body surface area–based dosing regimen for posaconazole prophylaxis in children with hematological malignancies.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Hematological Malignancy | Phase 4 | Status: COMPLETED